| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308570 | Kidney International | 2005 | 11 Pages |
Abstract
These results demonstrate that iNOS inhibition does not protect against Ang II-induced end-organ damage, while EPA treatment does. Our electromobility shift assay experiments revealed that EPA protection may involve inhibition of AP-1- and NF-κB-dependent pathways.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jorgen Theuer, Erdenechimeg Shagdarsuren, Dominik N. Muller, E.V.A. Kaergel, Horst Honeck, Joon-Keun Park, Anette Fiebeler, Ralf Dechend, Hermann Haller, Friedrich C. Luft, Wolf-Hagen Schunck,